Biological workers possess a fatal structural flaw: they can unionize. In Michigan, 10,000 registered nurses at Corewell Health have voted to authorize a strike, seeking to extract premium wages from a nonprofit hospital system. In California, 2,400 mental health therapists have walked out to protest management's demands to accelerate patient charting using artificial intelligence. To the market, these walkouts are not moral crises. They are explicit signals that human labour has become an unmanageable margin risk. Capital is responding with characteristic efficiency by routing around the friction. As healthcare workers demand increased compensation, institutional investors are financing their permanent redundancy. The same dynamic is playing out across the agricultural sector, where German startup eternal.ag just raised €8 million to deploy fully autonomous tomato-harvesting robots. The firm utilizes simulation-first development in NVIDIA environments to build machines capable of working 22-hour shifts without the logistical burden of overtime pay or collective bargaining. Similarly, Japanese industrial supplier Misumi Group has partnered with Oishii to advance robotic vertical farming systems. Whether it is a cardiac ICU or an indoor strawberry farm, the macroeconomic trajectory is identical. Biological labour is demanding a premium that the market simply refuses to bear. Strikes serve merely as the final catalyst for automation, justifying the heavy capital expenditure required to establish frictionless, autonomous systems.